Show simple item record

dc.contributor.authorRinas, Ursula
dc.contributor.authorGarcia-Fruitós, Elena
dc.contributor.authorCorchero, José Luis
dc.contributor.authorVázquez, Esther
dc.contributor.authorSeras-Franzoso, Joaquin
dc.contributor.authorVillaverde, Antonio
dc.date.accessioned2017-08-31T12:45:44Z
dc.date.available2017-08-31T12:45:44Z
dc.date.issued2017-02-27
dc.identifier.citationBacterial Inclusion Bodies: Discovering Their Better Half. 2017 Trends Biochem. Sci.en
dc.identifier.issn0968-0004
dc.identifier.pmid28254353
dc.identifier.doi10.1016/j.tibs.2017.01.005
dc.identifier.urihttp://hdl.handle.net/10033/621081
dc.description.abstractBacterial inclusion bodies (IBs) are functional, non-toxic amyloids occurring in recombinant bacteria showing analogies with secretory granules of the mammalian endocrine system. The scientific interest in these mesoscale protein aggregates has been historically masked by their status as a hurdle in recombinant protein production. However, progressive understanding of how the cell handles the quality of recombinant polypeptides and the main features of their intriguing molecular organization has stimulated the interest in inclusion bodies and spurred their use in diverse technological fields. The engineering and tailoring of IBs as functional protein particles for materials science and biomedicine is a good example of how formerly undesired bacterial byproducts can be rediscovered as promising functional materials for a broad spectrum of applications.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleBacterial Inclusion Bodies: Discovering Their Better Half.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalTrends in biochemical sciencesen
refterms.dateFOA2018-02-27T00:00:00Z
html.description.abstractBacterial inclusion bodies (IBs) are functional, non-toxic amyloids occurring in recombinant bacteria showing analogies with secretory granules of the mammalian endocrine system. The scientific interest in these mesoscale protein aggregates has been historically masked by their status as a hurdle in recombinant protein production. However, progressive understanding of how the cell handles the quality of recombinant polypeptides and the main features of their intriguing molecular organization has stimulated the interest in inclusion bodies and spurred their use in diverse technological fields. The engineering and tailoring of IBs as functional protein particles for materials science and biomedicine is a good example of how formerly undesired bacterial byproducts can be rediscovered as promising functional materials for a broad spectrum of applications.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Rinas et al.pdf
Size:
483.2Kb
Format:
PDF
Description:
original manuscript
Thumbnail
Name:
Outstanding Questions.pdf
Size:
30.67Kb
Format:
PDF
Description:
additional outstanding questions
Thumbnail
Name:
Figura 1 TIBS ver 2.tif
Size:
228.8Kb
Format:
TIFF image
Description:
figure 1
Thumbnail
Name:
Figura 2 TIBS ver 2.tif
Size:
116.2Kb
Format:
TIFF image
Description:
figure 2
Thumbnail
Name:
Figure 3 TIBS ver 2.tif
Size:
157.5Kb
Format:
TIFF image
Description:
figure 3
Thumbnail
Name:
Figure 4 TIBS ver 2.tif
Size:
530.2Kb
Format:
TIFF image
Description:
figure 4

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/